Actinium Pharmaceuticals Inc (ATNM) — Capital Reinvestment Ratio
Latest as of June 2022:
0.01x
Actinium Pharmaceuticals Inc (ATNM) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow ($27.92 Million) in capital expenditures ($270.00K). See Actinium Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$27.92 Million
USD
Capital Expenditures
$270.00K
USD
Data as of
Jun 2022
Most recent filing
Actinium Pharmaceuticals Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Actinium Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Actinium Pharmaceuticals Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Actinium Pharmaceuticals Inc from 2022 to 2022. For live market cap and broader valuation context, see Actinium Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $8.64 Million | $366.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow